US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 18.810
  • +0.110+0.59%
Close Nov 29 13:00 ET
  • 18.800
  • -0.010-0.05%
Post 17:01 ET
1.64BMarket Cap-4106P/E (TTM)

Travere Therapeutic Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
42.82%-42.56M
59.41%-39.83M
-34.60%-119.01M
-24.73%-325.36M
16.08%-64.37M
19.11%-74.43M
-166.64%-98.14M
-59.83%-88.42M
-242.15%-260.85M
13.16%-76.7M
Net income from continuing operations
38.65%-54.75M
37.99%-69.55M
-57.60%-136.06M
-13.54%-376.33M
-3.46%-88.6M
13.21%-89.24M
-67.33%-112.17M
-13.64%-86.33M
-52.54%-331.47M
3.53%-85.64M
Operating gains losses
----
----
----
----
----
----
----
----
--7.58M
--0
Depreciation and amortization
-2.06%11.24M
-5.50%10.35M
49.24%9.88M
85.96%38.53M
50.32%9.49M
1,547.04%11.48M
35.01%10.95M
-6.66%6.62M
62.55%20.72M
180.71%6.31M
Other non cash items
2,200.94%64.88M
155.84%4.99M
-94.13%364K
-164.29%-1.91M
262.18%3.91M
62.99%-3.09M
-293.98%-8.93M
-31.97%6.2M
-80.80%2.97M
85.14%-2.41M
Change In working capital
-37.65%-6.74M
-819.98%-60.74M
86.02%-2.95M
-3,011.43%-25.48M
265.76%7.1M
-139.17%-4.9M
-265.75%-6.6M
-86.18%-21.08M
-98.92%875K
-126.83%-4.28M
-Change in receivables
-193.12%-731K
-400.87%-1.74M
66.79%-1.55M
-687.94%-11.3M
-25.49%-8M
-86.28%785K
128.64%578K
-475.34%-4.66M
-107.99%-1.43M
-291.05%-6.38M
-Change in inventory
94.84%-246K
87.95%-1.42M
-257.65%-1.82M
-3,160.55%-39.42M
-59,028.95%-22.39M
-686.22%-4.77M
-517.50%-11.75M
-224.84%-510K
-1,133.33%-1.21M
-92.35%38K
-Change in prepaid assets
37.27%-3.05M
-71.62%866K
-4.81%-2.72M
10.37%-4.66M
90.20%-255K
-1,788.72%-4.85M
202.25%3.05M
-501.08%-2.6M
-261.08%-5.2M
-529.54%-2.6M
-Change in payables and accrued expense
-107.33%-554K
-1,120.74%-53.45M
63.52%-3.37M
94.27%47.08M
416.48%43.52M
-21.73%7.56M
-65.49%5.24M
-2.34%-9.23M
26.59%24.24M
-51.12%8.43M
-Change in other current liabilities
-2.48%-248K
-290.91%-2.88M
3,477.31%8.04M
74.02%-418K
56.67%799K
-3,125.00%-242K
-209.66%-737K
87.40%-238K
-243.28%-1.61M
-62.50%510K
-Change in other working capital
43.32%-1.91M
28.80%-2.12M
60.41%-1.52M
-20.50%-16.77M
-53.50%-6.57M
1.95%-3.38M
26.37%-2.98M
-79.12%-3.84M
-131.71%-13.91M
-103.76%-4.28M
Cash from discontinued investing activities
-99.67%50K
-39.19%45.34M
-127.65%-6.1M
15.29M
21.33%74.56M
22.06M
Operating cash flow
28.12%-42.51M
41.93%-40.24M
-46.71%-119.01M
-50.31%-280.02M
-28.98%-70.47M
-49.61%-59.13M
-88.28%-69.3M
-46.63%-81.12M
-1,159.40%-186.29M
-103.30%-54.64M
Investing cash flow
Cash flow from continuing investing activities
163.31%46.13M
221.47%28.61M
383.21%104.9M
-365.78%-151.63M
50.47%-18.18M
-822.85%-72.86M
39.76%-23.55M
-211.68%-37.04M
76.35%-32.55M
-597.98%-36.7M
Net PPE purchase and sale
--0
-2,633.33%-82K
--0
-249.74%-668K
16.67%-25K
---10K
---3K
-380.92%-630K
96.26%-191K
80.52%-30K
Net intangibles purchase and sale
-66.64%-8.19M
-1,906.55%-76.91M
76.35%-6.47M
-46.62%-41.59M
-32.11%-5.51M
35.49%-4.92M
66.50%-3.83M
-432.26%-27.34M
-48.90%-28.37M
17.42%-4.17M
Net investment purchase and sale
179.96%54.32M
635.59%105.6M
1,327.56%111.36M
-3,120.47%-109.37M
60.36%-12.65M
-483.53%-67.93M
28.65%-19.72M
-123.61%-9.07M
97.01%-3.4M
-353.81%-31.9M
Net other investing changes
----
----
----
----
----
----
----
----
---600K
----
Cash from discontinued investing activities
Investing cash flow
-65.40%46.13M
221.47%28.61M
383.21%104.9M
271.34%55.78M
53.82%-16.95M
1,222.73%133.32M
39.76%-23.55M
-211.68%-37.04M
76.35%-32.55M
-597.98%-36.7M
Financing cash flow
Cash flow from continuing financing activities
112.30%46K
-69.03%782K
-100.24%-525K
83.37%220.13M
-66.84%383K
-109.01%-374K
203.85%2.53M
91.02%217.6M
-49.51%120.05M
-97.06%1.16M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--104.93M
--0
Net common stock issuance
--0
--0
--0
878.25%191.2M
--0
--0
---1K
878.25%191.2M
-91.31%19.55M
--0
Proceeds from stock option exercised by employees
278.15%571K
-57.16%1.31M
--0
310.37%31.04M
-45.95%908K
-95.57%151K
29.61%3.05M
21,970.49%26.93M
-49.42%7.56M
-76.00%1.68M
Net other financing activities
0.00%-525K
0.00%-525K
0.00%-525K
82.47%-2.1M
0.00%-525K
-170.38%-525K
65.53%-525K
95.08%-525K
-470.57%-11.98M
-134.09%-525K
Cash from discontinued financing activities
0
0
0
44.25%-1.38M
57.12%-259K
-260K
-259K
-604K
59.39%-2.48M
-604K
Financing cash flow
107.26%46K
-65.49%782K
-100.24%-525K
86.06%218.75M
-77.50%124K
-127.83%-634K
172.68%2.27M
90.49%217M
-49.25%117.57M
-98.34%551K
Net cash flow
Beginning cash position
-54.44%32.29M
-73.20%43.25M
-5.69%58.18M
-62.78%61.69M
-4.69%144.24M
-60.57%70.87M
-37.10%161.38M
-62.78%61.69M
95.53%165.75M
0.67%151.34M
Current changes in cash
-95.02%3.67M
88.02%-10.85M
-114.80%-14.63M
94.58%-5.49M
3.85%-87.3M
370.72%73.55M
-20.66%-90.58M
7.72%98.84M
-227.76%-101.27M
-762.41%-90.79M
Effect of exchange rate changes
351.67%453K
-232.93%-109K
-134.55%-293K
170.90%1.98M
7.89%1.23M
85.65%-180K
104.71%82K
190.31%848K
-263.11%-2.79M
-33.66%1.14M
End cash Position
-74.76%36.41M
-54.44%32.29M
-73.20%43.25M
-5.69%58.18M
-5.69%58.18M
-4.69%144.24M
-60.57%70.87M
-37.10%161.38M
-62.78%61.69M
-62.78%61.69M
Free cash flow
20.86%-50.7M
-60.31%-117.24M
-15.02%-125.47M
-50.00%-322.28M
-29.18%-76M
-35.42%-64.06M
-51.99%-73.13M
-80.05%-109.08M
-451.70%-214.85M
-83.42%-58.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 42.82%-42.56M59.41%-39.83M-34.60%-119.01M-24.73%-325.36M16.08%-64.37M19.11%-74.43M-166.64%-98.14M-59.83%-88.42M-242.15%-260.85M13.16%-76.7M
Net income from continuing operations 38.65%-54.75M37.99%-69.55M-57.60%-136.06M-13.54%-376.33M-3.46%-88.6M13.21%-89.24M-67.33%-112.17M-13.64%-86.33M-52.54%-331.47M3.53%-85.64M
Operating gains losses ----------------------------------7.58M--0
Depreciation and amortization -2.06%11.24M-5.50%10.35M49.24%9.88M85.96%38.53M50.32%9.49M1,547.04%11.48M35.01%10.95M-6.66%6.62M62.55%20.72M180.71%6.31M
Other non cash items 2,200.94%64.88M155.84%4.99M-94.13%364K-164.29%-1.91M262.18%3.91M62.99%-3.09M-293.98%-8.93M-31.97%6.2M-80.80%2.97M85.14%-2.41M
Change In working capital -37.65%-6.74M-819.98%-60.74M86.02%-2.95M-3,011.43%-25.48M265.76%7.1M-139.17%-4.9M-265.75%-6.6M-86.18%-21.08M-98.92%875K-126.83%-4.28M
-Change in receivables -193.12%-731K-400.87%-1.74M66.79%-1.55M-687.94%-11.3M-25.49%-8M-86.28%785K128.64%578K-475.34%-4.66M-107.99%-1.43M-291.05%-6.38M
-Change in inventory 94.84%-246K87.95%-1.42M-257.65%-1.82M-3,160.55%-39.42M-59,028.95%-22.39M-686.22%-4.77M-517.50%-11.75M-224.84%-510K-1,133.33%-1.21M-92.35%38K
-Change in prepaid assets 37.27%-3.05M-71.62%866K-4.81%-2.72M10.37%-4.66M90.20%-255K-1,788.72%-4.85M202.25%3.05M-501.08%-2.6M-261.08%-5.2M-529.54%-2.6M
-Change in payables and accrued expense -107.33%-554K-1,120.74%-53.45M63.52%-3.37M94.27%47.08M416.48%43.52M-21.73%7.56M-65.49%5.24M-2.34%-9.23M26.59%24.24M-51.12%8.43M
-Change in other current liabilities -2.48%-248K-290.91%-2.88M3,477.31%8.04M74.02%-418K56.67%799K-3,125.00%-242K-209.66%-737K87.40%-238K-243.28%-1.61M-62.50%510K
-Change in other working capital 43.32%-1.91M28.80%-2.12M60.41%-1.52M-20.50%-16.77M-53.50%-6.57M1.95%-3.38M26.37%-2.98M-79.12%-3.84M-131.71%-13.91M-103.76%-4.28M
Cash from discontinued investing activities -99.67%50K-39.19%45.34M-127.65%-6.1M15.29M21.33%74.56M22.06M
Operating cash flow 28.12%-42.51M41.93%-40.24M-46.71%-119.01M-50.31%-280.02M-28.98%-70.47M-49.61%-59.13M-88.28%-69.3M-46.63%-81.12M-1,159.40%-186.29M-103.30%-54.64M
Investing cash flow
Cash flow from continuing investing activities 163.31%46.13M221.47%28.61M383.21%104.9M-365.78%-151.63M50.47%-18.18M-822.85%-72.86M39.76%-23.55M-211.68%-37.04M76.35%-32.55M-597.98%-36.7M
Net PPE purchase and sale --0-2,633.33%-82K--0-249.74%-668K16.67%-25K---10K---3K-380.92%-630K96.26%-191K80.52%-30K
Net intangibles purchase and sale -66.64%-8.19M-1,906.55%-76.91M76.35%-6.47M-46.62%-41.59M-32.11%-5.51M35.49%-4.92M66.50%-3.83M-432.26%-27.34M-48.90%-28.37M17.42%-4.17M
Net investment purchase and sale 179.96%54.32M635.59%105.6M1,327.56%111.36M-3,120.47%-109.37M60.36%-12.65M-483.53%-67.93M28.65%-19.72M-123.61%-9.07M97.01%-3.4M-353.81%-31.9M
Net other investing changes -----------------------------------600K----
Cash from discontinued investing activities
Investing cash flow -65.40%46.13M221.47%28.61M383.21%104.9M271.34%55.78M53.82%-16.95M1,222.73%133.32M39.76%-23.55M-211.68%-37.04M76.35%-32.55M-597.98%-36.7M
Financing cash flow
Cash flow from continuing financing activities 112.30%46K-69.03%782K-100.24%-525K83.37%220.13M-66.84%383K-109.01%-374K203.85%2.53M91.02%217.6M-49.51%120.05M-97.06%1.16M
Net issuance payments of debt --------------0------------------104.93M--0
Net common stock issuance --0--0--0878.25%191.2M--0--0---1K878.25%191.2M-91.31%19.55M--0
Proceeds from stock option exercised by employees 278.15%571K-57.16%1.31M--0310.37%31.04M-45.95%908K-95.57%151K29.61%3.05M21,970.49%26.93M-49.42%7.56M-76.00%1.68M
Net other financing activities 0.00%-525K0.00%-525K0.00%-525K82.47%-2.1M0.00%-525K-170.38%-525K65.53%-525K95.08%-525K-470.57%-11.98M-134.09%-525K
Cash from discontinued financing activities 00044.25%-1.38M57.12%-259K-260K-259K-604K59.39%-2.48M-604K
Financing cash flow 107.26%46K-65.49%782K-100.24%-525K86.06%218.75M-77.50%124K-127.83%-634K172.68%2.27M90.49%217M-49.25%117.57M-98.34%551K
Net cash flow
Beginning cash position -54.44%32.29M-73.20%43.25M-5.69%58.18M-62.78%61.69M-4.69%144.24M-60.57%70.87M-37.10%161.38M-62.78%61.69M95.53%165.75M0.67%151.34M
Current changes in cash -95.02%3.67M88.02%-10.85M-114.80%-14.63M94.58%-5.49M3.85%-87.3M370.72%73.55M-20.66%-90.58M7.72%98.84M-227.76%-101.27M-762.41%-90.79M
Effect of exchange rate changes 351.67%453K-232.93%-109K-134.55%-293K170.90%1.98M7.89%1.23M85.65%-180K104.71%82K190.31%848K-263.11%-2.79M-33.66%1.14M
End cash Position -74.76%36.41M-54.44%32.29M-73.20%43.25M-5.69%58.18M-5.69%58.18M-4.69%144.24M-60.57%70.87M-37.10%161.38M-62.78%61.69M-62.78%61.69M
Free cash flow 20.86%-50.7M-60.31%-117.24M-15.02%-125.47M-50.00%-322.28M-29.18%-76M-35.42%-64.06M-51.99%-73.13M-80.05%-109.08M-451.70%-214.85M-83.42%-58.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data